Payer Overview

BUPA INS CO is an international health insurer with limited direct presence in the United States market. Nationally, the company reports $0 in US premium and therefore does not occupy a ranked position among US A&H payers. The firm’s US footprint is reported as 0 states and it estimates its total members as N/A, indicating that domestic membership and market penetration are not represented in the NAIC-derived US dataset.

BUPA INS CO operates through 0 affiliated subsidiaries. While the company has minimal on‑shore operations, it does report activity in US territories totaling $1.39M across 2 jurisdictions and a material foreign premium exposure of $105.74M in Aggregate Other Alien, underscoring that its business is concentrated outside the 50 states rather than within them.

Premium by Scope

BUPA INS CO’s premium is overwhelmingly concentrated in the foreign scope, with $105.74M (98.70%) of reported premium reported outside the US states and DC. The US territories represent a very small slice at $1.39M (1.30%), while on‑shore US states show no reported premium.

For providers evaluating this payer, the dominance of foreign premium suggests contracting and network strategy should focus on international operations rather than US state markets. The modest territory footprint may require targeted administrative arrangements for those jurisdictions but will not drive large-scale US provider negotiations.

BUPA INS CO does not report market share or premium in any of the 50 US states in the provided NAIC dataset. The absence of on‑shore state premium means there is no state‑level concentration to analyze within the continental United States. Providers should note that network leverage and contracting opportunities with BUPA INS CO will not be driven by US state membership volumes, as those figures are not available.

Because all reported premium is outside the 50 states, national concentration metrics within the US are not applicable. The company’s operational focus appears international, and any US territorial activity is minimal at $1.39M, so nationwide provider strategies should treat BUPA INS CO as a non‑material partner for domestic patient volumes.

State-by-State Market Position

BUPA INS CO shows no measurable presence in any US region based on the NAIC state‑level data provided. There are no states with top rankings or meaningful market share in the Northeast, Southeast, Midwest, West, or Southwest. This distribution — effectively a lack of distribution — means multi‑state provider groups will not find scale opportunities with BUPA INS CO within the 50 states.

The geographic absence implies that contracting discussions for US providers will be driven by the insurer’s international and limited territorial operations rather than by regional US market dynamics. For multi‑state health systems focused on domestic volumes, BUPA INS CO is not a primary commercial target given the available data.

Estimated Member Demographics

Data not available.

Without age band or member count data, it is not possible to interpret the demographic profile or identify which age bands are largest nationally, nor to assess state-level age distribution.

Estimated Members by State

Data not available.

Without state-level member counts, it is not possible to analyze the geographic distribution of estimated members for BUPA INS CO. Providers should be aware that the payer's market share and premium volume are concentrated in "Aggregate Other Alien," with much smaller presence in U.S. Virgin Islands and Puerto Rico, but member counts are not reported.